DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

American College of Cardiology

DECEMBER 2, 2024

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule on Nov. Of note, the 2025 PFS conversion factor is $32.3465, a reduction of 2.83% from $33.2875 in 2024.

Medicare 45

Medicare CMS Medicaid Article 45

American College of Cardiology

JANUARY 8, 2025

The Centers for Medicare and Medicaid Services (CMS) has temporarily reassigned coronary CT angiography (CCTA) codes 75572-75574 from ambulatory payment classification (APC) 5571 to APC 5572 in the 2025 Outpatient Prospective Payment System (OPPS) final rule. in 2024 to $357.13 in 2025.

Reimbursement 45

Reimbursement CMS Medicaid Medicare 45

DAIC

MAY 2, 2024

Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. , The CardiAMP cell therapy trials for the indications of both chronic myocardial ischemia and ischemic heart failure are covered by the Center for Medicare and Medicaid for both treatment and control procedures.

Ischemia 95

Ischemia Angina Heart Failure Outcomes 95

CardiacWire

MARCH 24, 2024

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

Medicare 59

Medicare Obesity CMS Medicaid 59

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. You pick the quality measures that best fit your practice.

Medicare 52

Medicare CMS Document Technology 52

DAIC

JUNE 4, 2024

Even when social determinants of health (SDOH) are screened, they do not guide the development of actionable clinical care plans that are meaningful to the patient for their health management or recovery. This missing puzzle piece matters now more than ever.

Stroke 115

Stroke Strokes Innovation Research 115

DAIC

MARCH 5, 2024

HIMSS 2024 will be held March 11-15 in Orlando, FL. Andrea Fletcher , Chief Digital Strategy Officer and Director of the Digital Service at Centers for Medicare and Medicaid Services ( CMS ) will present, “ Teaching the Elephant to Dance: Digital Transformation in the United States ” on March 13 in an afternoon education session.

CMS 52

CMS COVID-19 Medicare Education 52

DAIC

MARCH 13, 2024

Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , We are pleased that CMS has provided coverage support for the confirmatory CardiAMP Heart Failure II study.” said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 14, 2024

The letter noted that the AMA was also pleased with the letter to health care leaders that Secretary Becerra and Acting Secretary Su sent on March 10, 2024. AMA is hearing reports that despite CMS instructions, some MACs are still requiring a waiver to accept paper claims. CMS should ensure that MACs allow paper claims without waivers.

CMS 101

CMS Medicare Medicaid Technology 101

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 09:08 July 25, 2024 — BioCardia, Inc. , The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

MARCH 7, 2024

As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence. billion, and expected to reach $3.18 Rao, MD, FACR, from Thomas Jefferson University Hospitals.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

DAIC

MARCH 3, 2025

GE HealthCare will mark the commercial launch of Flyrcado at the annual American College of Cardiology congress in Chicago from March 29-31, 2025, and expects to receive pass-through status from the US Centers for Medicaid and Medicare (CMS) shortly thereafter, enabling separate reimbursement for Flyrcado in the hospital outpatient setting.

Coronary Artery Disease 52

Coronary Artery Disease Ischemia Exercise Hospital 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A49-A49, February 1, 2024. With the CMS change CAS use could increase further. Annual usage of CEA declined from 51.6 cases/100,000 population in both sexes combined (APC -5.4%, 95%CI -6.0 and women (APC 15.2%, 95%CI 10.2 to 20.4) (Figure 1).Conclusion:Despite

CMS 40

CMS Medicaid Medicare Inpatient 40

American College of Cardiology

NOVEMBER 7, 2024

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule on Nov. Of note, the 2025 PFS conversion factor is $32.3465, reduced 2.83% from $33.2875 in 2024.

Medicare 40

Medicare Reimbursement CMS Medicaid 40

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. TCT 2024 4 WHO.

CMS 52

CMS Blood Pressure Medicare Hypertension 52